Payton A-B Weidenbacher (Payton Weidenbacher, Payton A Weidenbacher)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Binding Protein

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

bioRxiv : the preprint server for biology

Nature biotechnology

Nature communications

Nature chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Theodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, Peter S Kim
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing. bioRxiv : the preprint server for biology (2024)
Theodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, Peter S Kim
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing. bioRxiv : the preprint server for biology (2024)
Theodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, Peter S Kim
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing. bioRxiv : the preprint server for biology (2024)
Theodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, Peter S Kim
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing. bioRxiv : the preprint server for biology (2024)
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mengyun Hu, Ozan S Kumru, Mary Kate Morris, Jane Fontenot, Lisa M Shirreff, Jonathan Do, Ya-Chen Cheng, Gayathri Vasudevan, Mark B Feinberg, Francois J Villinger, Carl Hanson, Sangeeta B Joshi, David B Volkin, Bali Pulendran, Peter S Kim
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nature communications 14 (1) (2023)
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mengyun Hu, Ozan S Kumru, Mary Kate Morris, Jane Fontenot, Lisa M Shirreff, Jonathan Do, Ya-Chen Cheng, Gayathri Vasudevan, Mark B Feinberg, Francois J Villinger, Carl Hanson, Sangeeta B Joshi, David B Volkin, Bali Pulendran, Peter S Kim
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nature communications 14 (1) (2023)
Brian L Hie, Varun R Shanker, Duo Xu, Theodora U J Bruun, Payton A-B Weidenbacher, Shaogeng Tang, Wesley Wu, John E Pak, Peter S Kim
Efficient evolution of human antibodies from general protein language models. Nature biotechnology (2023)
Brian L Hie, Varun R Shanker, Duo Xu, Theodora U J Bruun, Payton A-B Weidenbacher, Shaogeng Tang, Wesley Wu, John E Pak, Peter S Kim
Efficient evolution of human antibodies from general protein language models. Nature biotechnology (2023)
Ozan S Kumru, Mrinmoy Sanyal, Natalia Friedland, John Hickey, Richa Joshi, Payton A-B Weidenbacher, Jonathan Do, Ya-Chen Cheng, Peter S Kim, Sangeeta B Joshi, David B Volkin
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines. bioRxiv : the preprint server for biology (2023)
Brian L Hie, Varun R Shanker, Duo Xu, Theodora U J Bruun, Payton A-B Weidenbacher, Shaogeng Tang, Wesley Wu, John E Pak, Peter S Kim
Efficient evolution of human antibodies from general protein language models. Nature biotechnology (2023)
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mengyun Hu, Ozan S Kumru, Mary Kate Morris, Jane Fontenot, Lisa Shirreff, Jonathan Do, Ya-Chen Cheng, Gayathri Vasudevan, Mark B Feinberg, Francois J Villinger, Carl Hanson, Sangeeta B Joshi, David B Volkin, Bali Pulendran, Peter S Kim
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. bioRxiv : the preprint server for biology (2022)
Payton A-B Weidenbacher, Sriharshita Musunuri, Abigail E Powell, Shaogeng Tang, Jonathan Do, Mrinmoy Sanyal, Peter S Kim
Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development. Biochemistry (2022)
Payton A-B Weidenbacher, Eric Waltari, Izumi de Los Rios Kobara, Benjamin N Bell, Mary Kate Morris, Ya-Chen Cheng, Carl Hanson, John E Pak, Peter S Kim
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors. Nature chemical biology 18 (11) (2022)
Payton A-B Weidenbacher, Frances P Rodriguez-Rivera, Mrinmoy Sanyal, Joshua A Visser, Jonathan Do, Carolyn R Bertozzi, Peter S Kim
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold. ACS chemical biology 17 (5) (2022)